All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

  1. Hadron therapy in children – an update of the scientific evidence for 15 paediatric cancers

    KCE Reports 235 (2015)

    https://kce.fgov.be/en/hadron-therapy-in-children-%E2%80%93-an-update-of-the-scientific-evidence-for-15-paediatric-cancers

  2. HPV Vaccination for the Prevention of Cervical Cancer in Belgium: Health Technology Assessment

    KCE Reports 64 (2007)

    https://kce.fgov.be/en/hpv-vaccination-for-the-prevention-of-cervical-cancer-in-belgium-health-technology-assessment

  3. Innovative radiotherapy techniques: a multicentre time-driven activity-based costing study

    KCE Reports 198 (2013)

    https://kce.fgov.be/en/innovative-radiotherapy-techniques-a-multicentre-time-driven-activity-based-costing-study
  4. Illustration report 298

    MammaPrint® test for personalised management of adjuvant chemotherapy decisions in early breast cancer

    KCE Report 298 (2018) Breast cancer is the most commonly diagnosed cancer in women in Belgium and throughout the world. Provided this cancer is in the early stage, treatment is essentially locoregional, that is, via surgery alone or combined with radiation therapy. In theory, this treatment is enough to eradicate the tumour since it is still limited. However, it is known that about 30% of patients treated in this way are at risk of developing remote metastases, because metastatic cancerous cells are already present but undetectable at the time of diagnosis.

    https://kce.fgov.be/en/mammaprint%C2%AE-test-for-personalised-management-of-adjuvant-chemotherapy-decisions-in-early-breast

  5. Next generation sequencing gene panels for targeted therapy in oncology and haemato-oncology

    KCE Reports 240 (2015)

    https://kce.fgov.be/en/next-generation-sequencing-gene-panels-for-targeted-therapy-in-oncology-and-haemato-oncology

  6. Trastuzumab in Early Stage Breast Cancer

    KCE Reports 34 (2006) 30 June (2nd edition; 22 June 2006, 1st edition)

    https://kce.fgov.be/en/trastuzumab-in-early-stage-breast-cancer